Patents by Inventor David Robin Whiting

David Robin Whiting has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240075227
    Abstract: A positive airway pressure apparatus is automatically adjusting. Pressure increases in response to apnea events when the apparatus is in one or more responsive states. Pressure does not increase in response to apnea events when the apparatus is in a non-responsive state. The apparatus switches between responsive and nonresponsive states depending upon any of a number of different criteria that help differentiate between open airway apnea events and closed airway apnea events.
    Type: Application
    Filed: July 13, 2023
    Publication date: March 7, 2024
    Inventors: David Robin Whiting, Andrew Gordon Gerred, Fiona Elizabeth Cresswell
  • Patent number: 11744968
    Abstract: A positive airway pressure apparatus is automatically adjusting. Pressure increases in response to apnea events when the apparatus is in one or more responsive states. Pressure does not increase in response to apnea events when the apparatus is in a non-responsive state. The apparatus switches between responsive and nonresponsive states depending upon any of a number of different criteria that help differentiate between open airway apnea events and closed airway apnea events.
    Type: Grant
    Filed: July 1, 2021
    Date of Patent: September 5, 2023
    Assignee: Fisher & Paykel Healthcare Limited
    Inventors: David Robin Whiting, Andrew Gordon Gerred, Fiona Elizabeth Cresswell
  • Publication number: 20230130469
    Abstract: An automatic positive airway pressure (AutoPAP) therapy device can be configured such that the minimum and/or maximum pressures deliverable by the device can automatically change. The minimum and/or maximum pressures can change as a function of pressures delivered over the course of the current therapy session and/or over the course of prior therapy sessions. The minimum and/or maximum pressures can also change as a function of the presence, absence, type, severity, or length of sleep disordered breathing events (SDBE) detected by the device over the course of the current therapy session and/or over the course of prior therapy sessions.
    Type: Application
    Filed: December 21, 2022
    Publication date: April 27, 2023
    Inventors: David Robin Whiting, Simei Gomes Wysoski
  • Patent number: 11617846
    Abstract: A multi-night titration (MNT) process to find an optimal single therapeutic pressure of a CPAP device. This single therapeutic pressure can then be used on an on-going basis by the patient after the titration period. The MNT process differs from current auto adjusting processes used for titration (or ongoing use) in that the MNT process does not respond locally by adjusting pressures to individual events. With existing devices, the continuous adjustment of supplied air pressure always responds to one or a small number of events and thus fails to compensate for a patient's adaptation thereto, resulting in the supply of a less than optimal therapeutic pressure to the patient. While auto adjusting processes often capture and respond well to short-term and transient conditions, the MNT process of the current disclosure seeks to capture long term trends and find the most suitable average single pressure for a patient.
    Type: Grant
    Filed: April 16, 2020
    Date of Patent: April 4, 2023
    Assignees: FISHER & PAYKEL HEALTHCARE LIMITED, NEW YORK UNIVERSITY
    Inventors: David M. Rapoport, Indu Ayappa, Simei Gomes Wysoski, Sujeewa Wannigama, David Robin Whiting
  • Publication number: 20220409835
    Abstract: High flow therapy is used to treat Cheyne-Stokes respiration and other types of periodic respiration disorders by periodic application of high flow therapy, adjustment of high flow therapy flow rates and/or periodic additions of CO2 or O2 into the air flow provided to the patient.
    Type: Application
    Filed: September 1, 2022
    Publication date: December 29, 2022
    Inventors: Stanislav Tatkov, David Robin Whiting, Jonathan David Harwood
  • Patent number: 11464926
    Abstract: High flow therapy is used to treat Cheyne-Stokes respiration and other types of periodic respiration disorders by periodic application of high flow therapy, adjustment of high flow therapy flow rates and/or periodic additions of CO2 or O2 into the air flow provided to the patient.
    Type: Grant
    Filed: June 5, 2014
    Date of Patent: October 11, 2022
    Assignee: Fisher & Paykel Healthcare Limited
    Inventors: Stanislav Tatkov, David Robin Whiting, Jonathan David Harwood
  • Publication number: 20220313155
    Abstract: A method and system of determining a sleep stage of a user involves receiving a respiratory flow signal of a user, obtaining at least one respiratory feature from at least part of the respiratory flow signal, and determining a sleep stage from the at least one respiratory feature.
    Type: Application
    Filed: March 2, 2022
    Publication date: October 6, 2022
    Inventors: Simei Gomes Wysoski, David Robin Whiting
  • Patent number: 11298074
    Abstract: A method and system of determining a sleep stage of a user involves receiving a respiratory flow signal of a user, obtaining at least one respiratory feature from at least part of the respiratory flow signal, and determining a sleep stage from the at least one respiratory feature.
    Type: Grant
    Filed: December 8, 2016
    Date of Patent: April 12, 2022
    Assignee: Fisher & Paykel Healthcare Limited
    Inventors: Simei Gomes Wysoski, David Robin Whiting
  • Publication number: 20220047827
    Abstract: A positive airway pressure apparatus is automatically adjusting. Pressure increases in response to apnea events when the apparatus is in one or more responsive states. Pressure does not increase in response to apnea events when the apparatus is in a non-responsive state. The apparatus switches between responsive and nonresponsive states depending upon any of a number of different criteria that help differentiate between open airway apnea events and closed airway apnea events.
    Type: Application
    Filed: July 1, 2021
    Publication date: February 17, 2022
    Inventors: David Robin Whiting, Andrew Gordon Gerred, Fiona Elizabeth Cresswell
  • Publication number: 20220031984
    Abstract: An apparatus and method of controlling the delivery of therapeutic gas delivered to a patient undergoing positive airway pressure therapy is described. The method includes providing a flow of gas to a patient's airway at a pressure, obtaining information from the range of 0 to 25 Hz of the frequency domain of the flow, and adjusting the pressure based on the information. The apparatus includes a blower for providing a flow of gas to a patient's airway at a pressure, a sensor to measure a characteristic of the flow, a controller to obtain information from the range of 0 to 25 Hz of the frequency domain of the characteristic, and a pressure regulator for adjusting the pressure based on the information.
    Type: Application
    Filed: September 23, 2021
    Publication date: February 3, 2022
    Inventors: Lewis George Gradon, David Robin Whiting, Andrew Gordon Gerred, Gregory Martyn Smith, Fiona Elizabeth Cresswell
  • Publication number: 20210338951
    Abstract: Apparatuses and methods for detecting sleep apnea and classifying the events as obstructive sleep apnea (OSA) and/or central sleep apnea (CSA) are disclosed herein. The apparatuses can include respiratory treatment devices that have an auto adjusting algorithm that is able to classify a sleep apnea as CSA or OSA so that an appropriate pressure can be applied to the patient depending on the type of sleep apnea detected. The apparatuses and methods can use characteristics of at least one breath preceding the apnea event in classifying the event.
    Type: Application
    Filed: May 21, 2021
    Publication date: November 4, 2021
    Inventors: David Robin WHITING, Amol Man MALLA, Simei Gomes WYSOSKI
  • Patent number: 11129949
    Abstract: An apparatus and method of controlling the delivery of therapeutic gas delivered to a patient undergoing positive airway pressure therapy is described. The method includes providing a flow of gas to a patient's airway at a pressure, obtaining information from the range of 0 to 25 Hz of the frequency domain of the flow, and adjusting the pressure based on the information. The apparatus includes a blower for providing a flow of gas to a patient's airway at a pressure, a sensor to measure a characteristic of the flow, a controller to obtain information from the range of 0 to 25 Hz of the frequency domain of the characteristic, and a pressure regulator for adjusting the pressure based on the information.
    Type: Grant
    Filed: September 24, 2015
    Date of Patent: September 28, 2021
    Assignee: FISHER & PAYKEL HEALTHCARE LIMITED
    Inventors: Lewis George Gradon, David Robin Whiting, Andrew Gordon Gerred, Gregory Martyn Smith, Fiona Elizabeth Cresswell
  • Patent number: 11077267
    Abstract: A positive airway pressure apparatus is automatically adjusting. Pressure increases in response to apnea events when the apparatus is in one or more responsive states. Pressure does not increase in response to apnea events when the apparatus is in a non-responsive state. The apparatus switches between responsive and nonresponsive states depending upon any of a number of different criteria that help differentiate between open airway apnea events and closed airway apnea events.
    Type: Grant
    Filed: January 11, 2018
    Date of Patent: August 3, 2021
    Assignee: Fisher & Paykel Healthcare Limited
    Inventors: David Robin Whiting, Andrew Gordon Gerred, Fiona Elizabeth Cresswell
  • Publication number: 20210187218
    Abstract: Positive airway pressure (“PAP”) systems and methods are provided which supply a patient with a range of pressures for treatment when the patient is determined to be asleep, and an awake pressure for use when the patient is determined to be awake, the awake pressure configured for the comfort of the patient. The awake pressure is configured to be lower than the lower bound of the pressure range and can be a therapeutic or sub-therapeutic pressure. The PAP systems and methods disclosed herein advantageously allow for the pressure range to be tailored for effective treatment of sleep disordered breathing while allowing the awake pressure to be set for the comfort of the patient. This can advantageously increase both the efficacy of the treatment of SDB and patient compliance with the treatment.
    Type: Application
    Filed: February 23, 2021
    Publication date: June 24, 2021
    Inventors: Andrew Gordon Gerred, David Robin Whiting
  • Patent number: 11040159
    Abstract: Apparatuses and methods for detecting sleep apnea and classifying the events as obstructive sleep apnea (OSA) and/or central sleep apnea (CSA) are disclosed herein. The apparatuses can include respiratory treatment devices that have an auto adjusting algorithm that is able to classify a sleep apnea as CSA or OSA so that an appropriate pressure can be applied to the patient depending on the type of sleep apnea detected. The apparatuses and methods can use characteristics of at least one breath preceding the apnea event in classifying the event.
    Type: Grant
    Filed: July 23, 2019
    Date of Patent: June 22, 2021
    Assignee: Fisher & Paykel Healthcare Limited
    Inventors: David Robin Whiting, Amol Man Malla, Simei Gomes Wysoski
  • Patent number: 10953171
    Abstract: Positive airway pressure (“PAP”) systems and methods are provided which supply a patient with a range of pressures for treatment when the patient is determined to be asleep, and an awake pressure for use when the patient is determined to be awake, the awake pressure configured for the comfort of the patient. The awake pressure is configured to be lower than the lower bound of the pressure range and can be a therapeutic or sub-therapeutic pressure. The PAP systems and methods disclosed herein advantageously allow for the pressure range to be tailored for effective treatment of sleep disordered breathing while allowing the awake pressure to be set for the comfort of the patient. This can advantageously increase both the efficacy of the treatment of SDB and patient compliance with the treatment.
    Type: Grant
    Filed: March 27, 2015
    Date of Patent: March 23, 2021
    Assignee: Fisher & Paykel Healthcare Limited
    Inventors: Andrew Gordon Gerred, David Robin Whiting
  • Publication number: 20200238028
    Abstract: A multi-night titration (MNT) process to find an optimal single therapeutic pressure of a CPAP device. This single therapeutic pressure can then be used on an on-going basis by the patient after the titration period. The MNT process differs from current auto adjusting processes used for titration (or ongoing use) in that the MNT process does not respond locally by adjusting pressures to individual events. With existing devices, the continuous adjustment of supplied air pressure always responds to one or a small number of events and thus fails to compensate for a patient's adaptation thereto, resulting in the supply of a less than optimal therapeutic pressure to the patient. While auto adjusting processes often capture and respond well to short-term and transient conditions, the MNT process of the current disclosure seeks to capture long term trends and find the most suitable average single pressure for a patient.
    Type: Application
    Filed: April 16, 2020
    Publication date: July 30, 2020
    Inventors: David M. RAPOPORT, lndu AYAPPA, Simei Gomes WYSOSKI, Sujeewa WANNIGAMA, David Robin WHITING
  • Patent number: 10625036
    Abstract: A multi-night titration (MNT) process to find an optimal single therapeutic pressure of a CPAP device. This single therapeutic pressure can then be used on an on-going basis by the patient after the titration period. The MNT process differs from current auto adjusting processes used for titration (or ongoing use) in that the MNT process does not respond locally by adjusting pressures to individual events. With existing devices, the continuous adjustment of supplied air pressure always responds to one or a small number of events and thus fails to compensate for a patient's adaptation thereto, resulting in the supply of a less than optimal therapeutic pressure to the patient. While auto adjusting processes often capture and respond well to short-term and transient conditions, the MNT process of the current disclosure seeks to capture long term trends and find the most suitable average single pressure for a patient.
    Type: Grant
    Filed: May 23, 2019
    Date of Patent: April 21, 2020
    Assignees: Fisher & Paykel Healthcare Limited, New York University
    Inventors: David M. Rapoport, Indu Ayappa, Simei Gomes Wysoski, Sujeewa Wannigama, David Robin Whiting
  • Publication number: 20200038608
    Abstract: Apparatuses and methods for detecting sleep apnea and classifying the events as obstructive sleep apnea (OSA) and/or central sleep apnea (CSA) are disclosed herein. The apparatuses can include respiratory treatment devices that have an auto adjusting algorithm that is able to classify a sleep apnea as CSA or OSA so that an appropriate pressure can be applied to the patient depending on the type of sleep apnea detected. The apparatuses and methods can use characteristics of at least one breath preceding the apnea event in classifying the event.
    Type: Application
    Filed: July 23, 2019
    Publication date: February 6, 2020
    Inventors: David Robin Whiting, Amol Man Malla, Simei Gomes Wysoski
  • Patent number: D940729
    Type: Grant
    Filed: September 10, 2019
    Date of Patent: January 11, 2022
    Assignee: FISHER & PAYKEL HEALTHCARE LIMITED
    Inventors: Christopher Harding Campbell, Peter Chi-Yang Hsu, Hamish Chan, Simei Gomes Wysoski, David Robin Whiting, Malik Tivanka Rajiv Peiris